Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Updates in Polycystic Kidney Disease, 3/12/2021 8:00:00 AM - 3/12/2024 9:00:00 AM, Participants in Medicine Grand Rounds will be able to identify the most current treatment guidelines, innovations, and standards of practice, and apply them to improve the care of individual patients, promote health and wellness in the population, and achieve clinical quality and safety goals. These educational activities are grounded in principles of health equity, evidence based medicine, inter-professional teamwork, patient-centered care, and respect for human dignity.
Presenter
Cristian V. Riella, MD
Instructor in Medicine, Harvard Medical School
Physician-Scientist, Division of Nephrology
Beth Israel Deaconess Medical Center
About our Presenter
Dr. Cristian Riella completed his Internal Medicine residency at St. Elizabeth’s Medical Center, Tufts School of Medicine, and his Nephrology fellowship at Beth Israel Deaconess Medical Center. Dr. Riella’s research focuses on genetic causes of kidney diseases, particularly polycystic kidney disease and Apolipoprotein L1 nephropathy. He is also investigating how RNA editing modulates gene expression in kidney disease via innate immune activation and is involved in clinical trials testing novel therapies for autosomal dominant polycystic kidney diseases.
Learning Outcome(s)
Participants will be able to discuss the management of Autosomal Dominant Polycystic Kidney Disease, including indications for genetic testing and non-renal complications, and review the disease modifying therapies and lifestyle changes that can help control cyst growth and slow the progression of disease.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Cristian V. Riella, MD
Instructor in Medicine, Harvard Medical School
Physician-Scientist, Division of Nephrology
Beth Israel Deaconess Medical Center
About our Presenter
Dr. Cristian Riella completed his Internal Medicine residency at St. Elizabeth’s Medical Center, Tufts School of Medicine, and his Nephrology fellowship at Beth Israel Deaconess Medical Center. Dr. Riella’s research focuses on genetic causes of kidney diseases, particularly polycystic kidney disease and Apolipoprotein L1 nephropathy. He is also investigating how RNA editing modulates gene expression in kidney disease via innate immune activation and is involved in clinical trials testing novel therapies for autosomal dominant polycystic kidney diseases.
Learning Outcome(s)
Participants will be able to discuss the management of Autosomal Dominant Polycystic Kidney Disease, including indications for genetic testing and non-renal complications, and review the disease modifying therapies and lifestyle changes that can help control cyst growth and slow the progression of disease.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
